Duquesne Family Office »

Ascendis Pharma A S shares owned by Duquesne Family Office

Quarter-by-quarter ownership of Ascendis Pharma A S (ASND) shares owned by Duquesne Family Office from 13F filings

Historical chart of Duquesne Family Office investment in Ascendis Pharma A S

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma A S held by Duquesne Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma A S by Duquesne Family Office

Quarter filed Position value Share count Share price at filing
2024-09-30 $40M 265k 149.31

More positions owned by Duquesne Family Office

Natera (NTRA)
Coupang Cl A (CPNG)
Coherent Corp (COHR)
Seagate Technology Hldngs Pl Ord Shs (STX)
Philip Morris International (PM)
Woodward Governor Company (WWD)
Spdr Ser Tr S&p Regl Bkg (KRE)
MercadoLibre (MELI)
Freeport-Mcmoran CL B (FCX)
Flutter Entmt SHS (FLUT)
Kinder Morgan (KMI)
Teck Resources CL B (TECK)
Vistra Energy (VST)
Broadcom (AVGO)
Discover Financial Services (DFS)

View all positions for Duquesne Family Office

Top funds holding Ascendis Pharma A S

RA Capital Management
Westfield Capital Management Company
Artisan Partners Limited Partnership
Henderson Group
T. Rowe Price Associates
Capital Research and Management Company - Division 3
Massachusetts Financial Services
T. Rowe Price Investment Management
Franklin Resources
Invesco
Citadel Advisors
BlackRock
Point72 Asset Management
TimesSquare Capital Management
Brown Advisory Holdings Incorporated

View all funds holding Ascendis Pharma A S